4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-151305
President & CEO sold 93,458 shares at an average $13.88 ($1,296,799)
- President & CEO acquired 87,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-16 | Sale : show line 1 in the form | −5,958 | $13.96 | $83,174 | 122,908 | D |
| 2016-11-17 | Exercise or conversion : show line 2 in the form | +87,500 | $4.65 | $406,875 | 210,408 | D |
| 2016-11-17 | Sale : show line 3 in the form | −87,500 | $13.87 | $1,213,625 | 122,908 | D |
| Open-market sales · 93,458 sh · avg $13.88 · $1,296,799 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-11-17 | Exercise or conversion : show line 4 in the form Stock Option | −87,500 | $4.65 | 2017-02-22 | 87,500 | 262,500 | D |
Loading xslF345X03/doc4.xml…